Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for CBSTQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2025 689.46M
June 30, 2025 702.68M
March 31, 2025 710.75M
December 31, 2024 726.23M
September 30, 2024 746.70M
June 30, 2024 753.73M
March 31, 2024 769.92M
December 31, 2023 757.76M
September 30, 2023 797.61M
June 30, 2023 797.19M
March 31, 2023 791.70M
December 31, 2022 787.82M
September 30, 2022 870.70M
June 30, 2022 892.50M
March 31, 2022 952.74M
Date Value
December 31, 2021 825.69M
September 30, 2021 858.67M
June 30, 2021 871.23M
March 31, 2021 488.45M
December 31, 2020 440.58M
September 30, 2020 394.62M
June 30, 2020 181.66M
March 31, 2020 153.28M
December 31, 2019 135.34M
September 30, 2019 71.38M
June 30, 2019 72.76M
March 31, 2019 121.57M
December 31, 2018 119.03M
September 30, 2018 36.05M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
cbdMD, Inc. 4.934M
MedMen Enterprises, Inc. --
Australis Capital, Inc. --
ANI Pharmaceuticals, Inc. 896.90M
Corcept Therapeutics, Inc. 182.93M

Total Liabilities (Quarterly) Related Metrics